Cancer & Therapeutics

Cancer Therapeutics aims to address the challenges of tumour heterogeneity, cancer development, and drug resistance by utilising a growing number of technologies available to doctors in the treatment of this illness. It has gone through a paradigm shift away from classic cytotoxic medications and toward targeting proteins that are fundamental to the cancer phenotype. The discovery and development of HSP90 inhibitors has been sought by cancer therapies as a means of avoiding or overcoming medication resistance. All anticancer drugs work by inhibiting cell growth or normal function, DNA synthesis, and RNA and protein metabolite blocking or alteration.

  • Cancer stem cells
  • Kinase inhibitors
  • Personalised medicine
  • Protein–protein interactions

    Related Conference of Cancer & Therapeutics

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Cancer & Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in